KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
600671 Hangzhou Tianmushan Pharmaceutical Enterprise
- 9.36
- -0.38-3.90%
Market Closed Dec 13 15:00 CST
1.14BMarket Cap-78.66P/E (TTM)
9.78High9.26Low10.08KlotVolume9.74Open9.74Pre Close9.60MTurnover0.83%Turnover RatioLossP/E (Static)121.78MShares12.4152wk High34.04P/B1.14BFloat Cap5.8552wk Low10.23Limit Up121.72MShs Float39.71Historical High9.25Limit Down5.34%Amplitude0.84Historical Low--Dividend TTM9.53Avg Price5.17KlotAsk--Div YieldTTM100Lot Size4.10KlotBid
Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 38.57%122.13M | 51.99%76.12M | 66.96%37.29M | -10.73%133.61M | 4.60%88.14M | -12.06%50.08M | -16.01%22.34M | 19.05%149.68M | -2.52%84.26M | -3.87%56.95M |
| Refunds of taxes and levies | 120,999.55%40.08K | 120,999.55%40.08K | ---- | ---- | -99.99%33.1 | -99.99%33.1 | -97.70%33.1 | --57.03K | 37.51%534.43K | -34.68%253.85K |
| Cash received relating to other operating activities | -50.66%1.1M | -50.57%1.01M | -84.47%415.63K | -60.87%2.47M | -82.24%2.22M | -81.64%2.04M | -88.94%2.68M | -68.20%6.31M | 101.72%12.52M | 87.83%11.12M |
| Cash inflows from operating activities | 36.42%123.27M | 48.05%77.17M | 50.75%37.71M | -12.79%136.08M | -7.14%90.36M | -23.71%52.12M | -50.75%25.01M | 7.19%156.05M | 4.60%97.31M | 4.23%68.33M |
| Goods services cash paid | 73.02%105.6M | 65.43%67.73M | 12.30%20.47M | -21.96%85.32M | -4.39%61.03M | -1.07%40.94M | 15.57%18.23M | 51.74%109.33M | 81.21%63.84M | 73.79%41.38M |
| Staff behalf paid | 1.91%28.56M | -1.47%18.04M | -5.23%8.7M | 13.93%36.87M | 6.78%28.02M | 22.50%18.31M | 3.25%9.18M | -10.42%32.36M | 12.55%26.24M | 3.21%14.95M |
| All taxes paid | 57.91%7.13M | 40.77%5.17M | 14.07%3.31M | 101.44%6.13M | 21.82%4.51M | 80.33%3.68M | 85.10%2.91M | -63.09%3.05M | -56.82%3.71M | -65.01%2.04M |
| Cash paid relating to other operating activities | -18.45%20.93M | -26.21%14.35M | 31.55%8.79M | -8.14%28.18M | 25.22%25.67M | 39.12%19.45M | -77.78%6.68M | -44.80%30.68M | -27.87%20.5M | -7.99%13.98M |
| Cash outflows from operating activities | 36.05%162.22M | 27.83%105.3M | 11.57%41.28M | -10.78%156.51M | 4.34%119.24M | 13.86%82.38M | -34.30%37M | 1.98%175.42M | 19.61%114.29M | 21.98%72.35M |
| Net cash flows from operating activities | -34.88%-38.96M | 7.02%-28.13M | 70.19%-3.57M | -5.46%-20.43M | -70.12%-28.88M | -652.27%-30.25M | -116.64%-11.99M | 26.69%-19.37M | -574.94%-16.98M | -164.45%-4.02M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --30 | --30 | ---- | 16,698.00%167.98K | ---- | ---- | ---- | -99.70%1K | -99.70%1K | -99.70%1K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --1 | --1 | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | --358.61K | --358.61K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 35,863,856.00%358.64K | --358.64K | ---- | 16,698.10%167.98K | -99.90%1 | ---- | ---- | -99.82%1K | -99.70%1K | -99.70%1K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 189.80%12.26M | 48.01%3.67M | -25.16%857.66K | 154.69%8.96M | 152.15%4.23M | 129.79%2.48M | 368.00%1.15M | -25.38%3.52M | -55.93%1.68M | -50.16%1.08M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.2M | ---- |
| Net cash paid to acquire subsidiaries and other business units | --6.67M | --6.67M | --2.2M | ---- | ---- | ---- | ---- | --2.2M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -53.05%38.87K | --38.87K | ---- | ---- | --82.78K | ---- | ---- |
| Cash outflows from investing activities | 343.27%18.93M | 316.88%10.34M | 166.82%3.06M | 55.10%8.99M | 10.12%4.27M | 129.79%2.48M | 368.00%1.15M | 23.06%5.8M | 1.85%3.88M | -50.16%1.08M |
| Net cash flows from investing activities | -334.87%-18.57M | -302.42%-9.98M | -166.82%-3.06M | -52.23%-8.83M | -10.14%-4.27M | -130.00%-2.48M | -369.92%-1.15M | -39.48%-5.8M | -11.66%-3.88M | 41.09%-1.08M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --4.55M | --4.3M | ---- | 33,233.33%90M | ---- | ---- | ---- | --270K | --270K | --270K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --4.55M | --4.3M | ---- | ---- | ---- | ---- | ---- | ---- | --270K | --270K |
| Cash from borrowing | -42.61%110.45M | 93.02%95.45M | 46.51%72.45M | -7.24%102.45M | 74.24%192.45M | -13.93%49.45M | -10.82%49.45M | -20.60%110.45M | 1.24%110.45M | -34.34%57.45M |
| Cash received relating to other financing activities | 26.73%83.46M | 121.87%80.87M | 39.10%49.45M | -46.43%65.86M | -27.37%65.86M | -40.39%36.45M | 8.88%35.55M | 33.48%122.94M | 0.09%90.68M | 9.69%61.15M |
| Cash inflows from financing activities | -23.17%198.46M | 110.27%180.62M | 43.41%121.9M | 10.55%258.31M | 28.25%258.31M | -27.74%85.9M | -3.52%85M | 1.06%233.66M | 0.85%201.4M | -17.02%118.87M |
| Borrowing repayment | 22.45%125.45M | 153.69%125.45M | 107.80%102.76M | -8.88%102.56M | -8.97%102.45M | -16.96%49.45M | -11.78%49.45M | -22.82%112.55M | -2.79%112.55M | -39.72%59.55M |
| Dividend interest payment | 57.10%7.33M | 98.16%6.14M | 1.38%1.54M | 39.48%6.67M | -3.90%4.67M | -4.85%3.1M | -8.68%1.52M | -28.73%4.78M | -6.41%4.85M | -9.36%3.26M |
| -Including:Cash payments for dividends or profit to minority shareholders | --3.58M | --3.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 54.01%91.62M | 55.14%56.61M | 45.34%53.02M | 6.62%64.26M | 6.29%59.49M | -34.26%36.49M | 12.41%36.48M | 36.54%60.27M | 37.84%55.96M | 192.11%55.5M |
| Cash outflows from financing activities | 34.69%224.4M | 111.37%188.2M | 79.89%157.31M | -2.32%173.48M | -3.90%166.6M | -24.74%89.04M | -3.01%87.45M | -9.70%177.6M | 7.30%173.37M | -2.53%118.31M |
| Net cash flows from financing activities | -128.28%-25.93M | -141.62%-7.58M | -1,347.05%-35.41M | 51.32%84.83M | 227.12%91.71M | -659.35%-3.14M | -18.60%-2.45M | 62.38%56.06M | -26.48%28.03M | -97.44%560.88K |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -242.54%-83.46M | -27.37%-45.69M | -169.80%-42.04M | 79.91%55.57M | 715.53%58.55M | -690.32%-35.87M | -98.72%-15.58M | 683.55%30.89M | -77.66%7.18M | -117.27%-4.54M |
| Add:Begin period cash and cash equivalents | 131.09%97.96M | 131.09%97.96M | 131.09%97.96M | 268.46%42.39M | 268.45%42.39M | 268.45%42.39M | 278.66%42.39M | 52.12%11.51M | 51.91%11.51M | 51.91%11.51M |
| End period cash equivalent | -85.63%14.5M | 701.26%52.28M | 108.59%55.92M | 131.08%97.96M | 440.24%100.95M | -6.36%6.52M | 699.35%26.81M | 268.46%42.39M | -52.95%18.69M | -79.42%6.97M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Unitai Zhenqing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
